Cargando…

AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis

BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intellige...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlaeger, Sarah, Shit, Suprosanna, Eichinger, Paul, Hamann, Marco, Opfer, Roland, Krüger, Julia, Dieckmeyer, Michael, Schön, Simon, Mühlau, Mark, Zimmer, Claus, Kirschke, Jan S., Wiestler, Benedikt, Hedderich, Dennis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350445/
https://www.ncbi.nlm.nih.gov/pubmed/37454342
http://dx.doi.org/10.1186/s13244-023-01460-3
_version_ 1785074136685477888
author Schlaeger, Sarah
Shit, Suprosanna
Eichinger, Paul
Hamann, Marco
Opfer, Roland
Krüger, Julia
Dieckmeyer, Michael
Schön, Simon
Mühlau, Mark
Zimmer, Claus
Kirschke, Jan S.
Wiestler, Benedikt
Hedderich, Dennis M.
author_facet Schlaeger, Sarah
Shit, Suprosanna
Eichinger, Paul
Hamann, Marco
Opfer, Roland
Krüger, Julia
Dieckmeyer, Michael
Schön, Simon
Mühlau, Mark
Zimmer, Claus
Kirschke, Jan S.
Wiestler, Benedikt
Hedderich, Dennis M.
author_sort Schlaeger, Sarah
collection PubMed
description BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intelligence (AI) tools in the clinical routine is still rare. METHODS: A three-dimensional convolutional neural network for CE lesion segmentation was trained externally on 1488 datasets of 934 MS patients from 81 scanners using concatenated information from FLAIR and T1-weighted post-contrast imaging. This externally trained model was tested on an independent dataset comprising 504 T1-weighted post-contrast and FLAIR image datasets of MS patients from clinical routine. Two neuroradiologists (R1, R2) labeled CE lesions for gold standard definition in the clinical test dataset. The algorithmic output was evaluated on both patient- and lesion-level. RESULTS: On a patient-level, recall, specificity, precision, and accuracy of the AI tool to predict patients with CE lesions were 0.75, 0.99, 0.91, and 0.96. The agreement between the AI tool and both readers was within the range of inter-rater agreement (Cohen’s kappa; AI vs. R1: 0.69; AI vs. R2: 0.76; R1 vs. R2: 0.76). On a lesion-level, false negative lesions were predominately found in infratentorial location, significantly smaller, and at lower contrast than true positive lesions (p < 0.05). CONCLUSIONS: AI-based identification of CE lesions on brain MRI is feasible, approaching human reader performance in independent clinical data and might be of help as a second reader in the neuroradiological assessment of active inflammation in MS patients. CRITICAL RELEVANCE STATEMENT: Al-based detection of contrast-enhancing multiple sclerosis lesions approaches human reader performance, but careful visual inspection is still needed, especially for infratentorial, small and low-contrast lesions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01460-3.
format Online
Article
Text
id pubmed-10350445
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-103504452023-07-18 AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis Schlaeger, Sarah Shit, Suprosanna Eichinger, Paul Hamann, Marco Opfer, Roland Krüger, Julia Dieckmeyer, Michael Schön, Simon Mühlau, Mark Zimmer, Claus Kirschke, Jan S. Wiestler, Benedikt Hedderich, Dennis M. Insights Imaging Original Article BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intelligence (AI) tools in the clinical routine is still rare. METHODS: A three-dimensional convolutional neural network for CE lesion segmentation was trained externally on 1488 datasets of 934 MS patients from 81 scanners using concatenated information from FLAIR and T1-weighted post-contrast imaging. This externally trained model was tested on an independent dataset comprising 504 T1-weighted post-contrast and FLAIR image datasets of MS patients from clinical routine. Two neuroradiologists (R1, R2) labeled CE lesions for gold standard definition in the clinical test dataset. The algorithmic output was evaluated on both patient- and lesion-level. RESULTS: On a patient-level, recall, specificity, precision, and accuracy of the AI tool to predict patients with CE lesions were 0.75, 0.99, 0.91, and 0.96. The agreement between the AI tool and both readers was within the range of inter-rater agreement (Cohen’s kappa; AI vs. R1: 0.69; AI vs. R2: 0.76; R1 vs. R2: 0.76). On a lesion-level, false negative lesions were predominately found in infratentorial location, significantly smaller, and at lower contrast than true positive lesions (p < 0.05). CONCLUSIONS: AI-based identification of CE lesions on brain MRI is feasible, approaching human reader performance in independent clinical data and might be of help as a second reader in the neuroradiological assessment of active inflammation in MS patients. CRITICAL RELEVANCE STATEMENT: Al-based detection of contrast-enhancing multiple sclerosis lesions approaches human reader performance, but careful visual inspection is still needed, especially for infratentorial, small and low-contrast lesions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01460-3. Springer Vienna 2023-07-16 /pmc/articles/PMC10350445/ /pubmed/37454342 http://dx.doi.org/10.1186/s13244-023-01460-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schlaeger, Sarah
Shit, Suprosanna
Eichinger, Paul
Hamann, Marco
Opfer, Roland
Krüger, Julia
Dieckmeyer, Michael
Schön, Simon
Mühlau, Mark
Zimmer, Claus
Kirschke, Jan S.
Wiestler, Benedikt
Hedderich, Dennis M.
AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title_full AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title_fullStr AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title_full_unstemmed AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title_short AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
title_sort ai-based detection of contrast-enhancing mri lesions in patients with multiple sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350445/
https://www.ncbi.nlm.nih.gov/pubmed/37454342
http://dx.doi.org/10.1186/s13244-023-01460-3
work_keys_str_mv AT schlaegersarah aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT shitsuprosanna aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT eichingerpaul aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT hamannmarco aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT opferroland aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT krugerjulia aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT dieckmeyermichael aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT schonsimon aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT muhlaumark aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT zimmerclaus aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT kirschkejans aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT wiestlerbenedikt aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis
AT hedderichdennism aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis